Synthetic Biologics, Inc. (SYN)
Net Income Growth
75.36%
Quarterly · Period ending:
SYN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported75.36%period ending
Latest reported75.36%period ending
SYN Quarterly Net Income YoY % (36.71% → 75.36%)
Year-over-year change
High-resolution chart · PNG
SYN net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 75.3638% | |
| 52.729% | |
| 68.2024% | |
| -57.0226% | |
| -63.572% | |
| 38.5145% | |
| -1.8022% | |
| -4.7485% | |
| 2.1652% | |
| -64.1308% | |
| -56.3067% | |
| -68.5726% | |
| -149.6444% | |
| -55.6348% | |
| -11.4405% | |
| 14.4399% | |
| 32.8344% | |
| 58.9258% | |
| 18.8049% | |
| 15.6036% | |
| 1.04% | |
| -39.1304% | |
| 15.8685% | |
| -51.6408% | |
| -211.3333% | |
| 66.3065% | |
| 1.3631% | |
| 18.6226% | |
| 220% | |
| -30.7554% | |
| 25.1144% | |
| 73.7575% | |
| 78.3737% | |
| -23.3097% | |
| 58.2911% | |
| 12.2431% | |
| -69.4753% | |
| -37.9633% | |
| -199.0123% | |
| -221.9906% | |
| -53.4091% | |
| -45.7838% | |
| -82.459% | |
| -72.2621% | |
| 64.9925% | |
| -74.5078% | |
| -33.3868% | |
| -85.6667% | |
| -278.8783% | |
| -75.7775% | |
| -11.4355% | |
| 45.1168% | |
| -265.8078% | |
| -49.8262% | |
| -271.456% | |
| -101.0498% | |
| 21.8364% | |
| -17.0523% | |
| 211.3958% | |
| 2.3133% | |
| -21.7065% | |
| 56.183% | |
| 50.356% | |
| 63.9653% | |
| 71.0355% | |
| 32.6319% | |
| -0.5226% | |
| -8.4197% | |
| 22.7817% | |
| -70,199.7017% | |
| -40,296.5849% | |
| -452.7379% | |
| -40,817.15% | |
| 69.83% | |
| 1,629.5463% | |
| 1,279.2386% | |
| 611.1908% | |
| 71.8896% | |
| 66.8141% | |
| 49.7562% | |
| -39.3736% | |
| -98.2766% | |
| -88.6714% | |
| -96.7029% | |
| -64.7199% | |
| -8.4634% | |
| 87.9252% | |
| 12.1239% | |
| 7.746% | |
| -21.4242% | |
| -1,376.0876% | |
| 28.5714% | |
| 88.7218% | |
| 47.8261% | |
| 40% | |
| -10.5263% | |
| -291.1765% | |
| 14.8148% | |
| 28.5714% | |
| -18.75% |